Selective targeting of α4β1 integrin attenuates murine graft versus host disease
- 8 March 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 34 (11), 3100-3104
- https://doi.org/10.1038/s41375-020-0786-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host DiseaseThe Journal of Immunology, 2015
- Current and emerging strategies for the prevention of graft-versus-host diseaseNature Reviews Clinical Oncology, 2014
- CD25 and CD69 induction by α4β1 outside-in signalling requires TCR early signalling complex proteinsBiochemical Journal, 2013
- IFNγR signaling mediates alloreactive T-cell trafficking and GVHDBlood, 2012
- Tissue-tropic effector T cells: generation and targeting opportunitiesNature Reviews Immunology, 2006
- Leukocyte migration and graft-versus-host diseaseBlood, 2005
- VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responsesProceedings of the National Academy of Sciences of the United States of America, 2004
- LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host diseaseBlood, 2004
- An Assessment of the Mechanistic Differences Between Two Integrin α4β1Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune EncephalomyelitisThe Journal of pharmacology and experimental therapeutics, 2003